<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-040584</identifier>
<setSpec>0213-2885</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Cardiovascular risk factors in renal transplantation</dc:title>
<dc:description xml:lang="en">Survival of the renal graft has progressivery increased over the last few years. Tbe most frequent causes of renal graft loss are death of the patient with a functional graft (basicaUy cardiovascular in etiology) and chronic nepbropathy ofthe graft.    Renal-transplanted patients show a high prevalence of cardiovasculuar events following transplantation.    Additionaly to the wellknown factors of cardiovascular risk (diabetes, hypertension, dyslipemia and smoking habit), other factors are gaining special importance, and outstanding among them are hyperhomocysteinemia, microinflamation markers and the renal function. We need a strict control of them for to improve these conditions</dc:description>
<dc:creator>Guirado, L</dc:creator>
<dc:creator>Díaz, J. M</dc:creator>
<dc:creator>Facundo, C</dc:creator>
<dc:creator>Solá, R</dc:creator>
<dc:creator>Sainz, Z</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La supervivencia del injerto renal ha ido aumentando progresivamente en los últimos años. Las causas de pérdida del injerto son la muerte del paciente con injerto funcionante (fundamentalmente por causa cardiovascular) y la nefropatía crónica del trasplante.    Tanto en la muerte de origen cardiovascular como en la nefropatia crónica del trasplante juegan un papel fundamental tanto los factores de riesgo cardiovascular bien conocidos (diabetes mellitus, hipertensión, dislipemia y tabaquismo) como los de reciente denominación (hiperhomocisteinemia, carcadores de microinflamación y grado de función renal).    La disminución de la morbimortalidad cardiovascular y la mejoría de la supervivencia del injerto renal exigen un control estricto de todos estos factores de riesgo cardiovascular</dc:description>
<dc:source>Actas Fund. Puigvert;24(1): 30-37, ene. 2005.</dc:source>
<dc:identifier>ibc-040584</dc:identifier>
<dc:title xml:lang="es">Factores de riesgo cardiovascular en trasplante renal</dc:title>
<dc:subject>^d7156^s22012</dc:subject>
<dc:subject>^d29475^s22047</dc:subject>
<dc:subject>^d28631</dc:subject>
<dc:subject>^d2359^s22009</dc:subject>
<dc:subject>^d50495^s22053</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2359^s22047</dc:subject>
<dc:subject>^d29475^s22074</dc:subject>
<dc:subject>^d29475^s28898</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d3951^s22009</dc:subject>
<dc:subject>^d3951^s22027</dc:subject>
<dc:subject>^d50495^s22009</dc:subject>
<dc:subject>^d3942^s22012</dc:subject>
<dc:subject>^d3951^s22054</dc:subject>
<dc:type>article</dc:type>
<dc:date>200501</dc:date>
</metadata>
</record>
</ibecs-document>
